How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,916 results for

Hip Injection

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Comparison of Single Intra-articular Injection of Hyruan-One With Hylan G-F 20 in Knee Osteoarthritis

conservative treatment at least 3 months Kellgren-Lawrence grade I-III Gave informed consent Can do questionnaires Exclusion Criteria: Severe deformity (varus or values from mechanical axis more than 5 degrees Allergy to hyaluronic acid Pain on hip or ankle Post-traumatic or post surgery of lower extremity Post infection of knee Previous hyaluronic acid injection within 6 months Pregnancy or lactation Underlying Rheumatoid arthritis, stroke, malignancy, venous occlusion Contacts and Locations Go (...) Comparison of Single Intra-articular Injection of Hyruan-One With Hylan G-F 20 in Knee Osteoarthritis Comparison of Single Intra-articular Injection of Hyruan-One With Hylan G-F 20 in Knee Osteoarthritis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please

2018 Clinical Trials

102. Osteoarthritis Shoulder Injection Study

a patient-specific duration that often provide relief for a month before the effects begin to taper with most individuals returning to baseline by 2-3 months post injection. Unfortunately, data on intraarticular injections is not robust and primarily focused on hip, knee, and disease processes rather than the glenohumeral joint. For example, steroid concentrations have been studied in adhesive capsulitis, where 20 and 40mg of triamcinolone acenotide were used with no statistical significance between (...) Osteoarthritis Shoulder Injection Study Osteoarthritis Shoulder Injection Study - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Osteoarthritis Shoulder Injection Study The safety and scientific validity

2018 Clinical Trials

103. American Association of Hip and Knee Surgeons Clinical Practice Guideline on Tranexamic Acid in Total Joint Arthroplasty

, Lopez-Picado A, Remon M, Fondarella A, Iriarte I, Bastida R, Rodríguez-Gascón A, Achaerandio M, Iturricastillo M, Aizpuru F, Valero C, Tobalina R, Hernanz R. Tranexamic Acid Compared with Placebo for Reducing Total Blood Loss in Hip Replacement Surgery: A Randomized Clinical Trial. In: Anesthesia and analgesia. 986. 2016 9. Lin P, Hsu C, Huang C, Chen W, Wang J. The blood-saving effect of tranexamic acid in minimally invasive total knee replacement: is an additional pre-operative injection effective (...) American Association of Hip and Knee Surgeons Clinical Practice Guideline on Tranexamic Acid in Total Joint Arthroplasty Tranexamic Acid in Total Joint Arthroplasty: The Endorsed Clinical Practice Guides of the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, The Hip Society, and The Knee Society Fillingham YA 1 , Ramkumar DB 2 , Jevsevar DS 2 , Yates AJ 3 , Sayeed SA 4 , Sah AP 5 , Bini SA 6

2018 American Academy of Orthopaedic Surgeons

104. Monoclonal Antibodies for Osteoarthritis of the Hip or Knee

therapeutic options include non-pharmacologic therapy and topical analgesics, followed by oral analgesics and injectable agents, followed by surgery for end-stage disease. OA typically affects the knees, hips, hands, spine, and feet. Treatment with anti-nerve growth factors monoclonal antibodies (anti-NGFs) may improve joint pain and physical function, as nerve growth factor is associated with chronic pain conditions, and is elevated in the joints of patients with osteoarthritis. Within the indication (...) investigated as an intravenous infusion; a subcutaneous injection was subsequently developed. 18-26 The doses used in the completed phase III clinical trials for IV tanezumab were 2.5 mg, 5 mg, or 10 mg administered every eight weeks. 13 The doses used in the ongoing phase III clinical trials for SC tanezumab are 2.5 mg and 5 mg, administered every eight weeks. 39-41 Target Population For OA, tanezumab has been studied in adults with hip or knee OA who do not respond to or who are intolerant to currently

2018 CADTH - Issues in Emerging Health Technologies

105. Guideline for the management of knee and hip osteoarthritis

OA, with monitoring of possible adverse effects, then discontinue use if not effective. • Corticosteroid injections could be offered for short-term symptom relief for some people with knee and/or hip OA, but care should be taken with repeated injections because of potential harm. • Duloxetine could be considered for some people with knee and/or hip OA when other forms of pain relief are inadequate. • There is a strong recommendation against the use of the following – oral and transdermal opioids (...) – viscosupplementation injection for hip OA – doxycycline – strontium ranelate – interleukin-1 (IL-1) inhibitors – stem cell therapy. • There is a conditional recommendation against the use of the following – capsaicin for knee and/or hip OA – bisphosphonates – calcitonin – anti-nerve growth factor (NGF) – colchicine – methotrexate – viscosupplementation injection for knee OA – dextrose prolotherapy – omega 3 fatty acids – diacerein.3 Guideline for the management of knee and hip osteoarthritis Second edition • Due

2018 Clinical Practice Guidelines Portal

106. Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 13: Injection therapies, low-back pain, and lumbar fusion

Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 13: Injection therapies, low-back pain, and lumbar fusion J Neurosurg Spine 21:79–90, 2014 79 ©AANS, 2014 J Neurosurg: Spine / Volume 21 / July 2014 Therapeutic Recommendations There is no new evidence that conflicts with the pre - vious recommendations regarding injection therapies pub- lished in the original version of the “Guidelines for the per - formance of fusion procedures (...) for degenerative disease of the lumbar spine.” 27 Lumbar Epidural Steroid Injections Grade C Lumbar epidural steroid injections (ESIs) are an op- tion for the short-term relief of chronic low-back pain without radiculopathy in patients with degenerative dis- ease of the lumbar spine (Level III evidence). Caudal ESIs are an option for decreasing low-back pain of greater than 6 weeks’ duration, without radiculop - athy, in patients with degenerative disease of the lumbar spine (Level III evidence). Lumbar Facet

2014 Congress of Neurological Surgeons

107. Hip-related groin pain, patient characteristics and patient-reported outcomes in patients referred to tertiary care due to longstanding hip and groin pain: a cross-sectional study. Full Text available with Trip Pro

and categorized into hip-related groin pain or non-hip-related groin pain using diagnostic criteria based on current best evidence (clinical examination, radiological examination and intra-articular block injection). Patient characteristics (gender (%), age (years), BMI (kg/m2)), results from the Hip Sports Activity Scale (HSAS), the SF-36, the Copenhagen Hip and Groin Outcome Score (HAGOS), and pain distribution (pain manikin) were collected. Parametric and non-parametric statistics were used as appropriate (...) Hip-related groin pain, patient characteristics and patient-reported outcomes in patients referred to tertiary care due to longstanding hip and groin pain: a cross-sectional study. Due to advances in hip arthroscopy, the number of surgical procedures has increased dramatically. The diagnostic challenge in patients with longstanding hip and groin pain, as well as the increasing number of hip arthroscopies, may lead to a higher number of patients referred to tertiary care for consideration

2019 BMC Musculoskeletal Disorders

108. What Are the Costs of Hip Osteoarthritis in the Year Prior to a Total Hip Arthroplasty? (Abstract)

of total 1-year costs was accounted for by office visits (35% in Commercial; 41% in MA) followed by pain medications (28% in Commercial; 35% in MA). Conservative treatments (steroid injections, hyaluronic acid injections, physical therapy, and pain medications) alone accounted for 40%-44% of the total 1-year costs prior to a THA. A high healthcare utilization within the last 3 months prior to surgery was noted for opioids and steroid injections.On average, $500-$800/patient is spent on hip (...) What Are the Costs of Hip Osteoarthritis in the Year Prior to a Total Hip Arthroplasty? The majority of the cost analysis literature on total hip arthroplasties (THAs) has been focused around the perioperative and postoperative period, with preoperative costs being overlooked.The Humana Administrative Claims database was used to identify Medicare Advantage (MA) and Commercial beneficiaries undergoing elective primary THAs. Preoperative healthcare resource utilization in the year prior to a THA

2019 Journal of Arthroplasty

109. Impact of Local Infiltration Analgesia on the Quality of Recovery After Anterior Total Hip Arthroplasty: A Randomized, Triple-Blind, Placebo-Controlled Trial (Abstract)

Impact of Local Infiltration Analgesia on the Quality of Recovery After Anterior Total Hip Arthroplasty: A Randomized, Triple-Blind, Placebo-Controlled Trial Local infiltration analgesia (LIA) is commonly used in anterior total hip arthroplasty (THA) surgery; however, evidence for its efficacy is lacking. We hypothesized that LIA with 0.2% ropivacaine when compared with injection of placebo (0.9% saline) would improve patient quality of recovery on postoperative day (POD) 1, as measured

2020 EvidenceUpdates

110. Reduction of Postoperative Hip Arthroscopy Pain With an Ultrasound-Guided Fascia Iliaca Block: A Prospective Randomized Controlled Trial

differ between the groups. Intraoperative and PACU narcotics did not differ significantly between the groups. Readmission rates, PACU recovery time, and postoperative nausea and vomiting did not significantly differ between the groups. There were no associated complications in either group. Conclusion: Ultrasound-guided fascia iliaca block for hip arthroscopy had no clinical advantage when compared with onetime intra-articular ropivacaine injection. Registration: (ClinicalTrials.gov identifier (...) Reduction of Postoperative Hip Arthroscopy Pain With an Ultrasound-Guided Fascia Iliaca Block: A Prospective Randomized Controlled Trial Reduction of Postoperative Hip Arthroscopy Pain With an Ultrasound-Guided Fascia Iliaca Block: A Prospective Randomized Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National

2020 EvidenceUpdates

111. Ultrasound-guided hip injections: a comparative study with fluoroscopy-guided injections. (Abstract)

Ultrasound-guided hip injections: a comparative study with fluoroscopy-guided injections. The purpose was to assess ultrasound-guided injections through patient satisfaction in a comparative internally controlled study of fluoroscopic versus ultrasound technique and to quantitate the reliability of the ultrasound method. In addition, the reliability of the ultrasound method was quantitated.This study consisted of the first 50 consecutive patients to undergo ultrasound-guided intra-articular (...) injection of the hip (by a nurse practitioner) and who had previously undergone fluoroscopy-guided intra-articular injections by our center's fellowship-trained musculoskeletal radiologists. The patients rated the ultrasound and fluoroscopic experiences on a scale from 1 to 10 for convenience and pain; in addition, they indicated their preference between the 2 techniques. Success of the injection was documented among a total of 206 consecutive patients who underwent ultrasound-guided injections during

2014 Arthroscopy

112. Clinical Practice Guideline on the Management of Osteoarthritis of the Hip

” strength studies with consistent findings, or evidence from a single “High” quality study for recommending for or against the intervention. 6 INTRAARTICULAR INJECTABLES a) Strong evidence supports the use of intraarticular corticosteroids to improve function and reduce pain in the short-term for patients with symptomatic osteoarthritis of the hip. Strength of Recommendation: Strong Evidence Description: Evidence from two or more “High” strength studies with consistent findings for recommending (...) Clinical Practice Guideline on the Management of Osteoarthritis of the Hip MANAGEMENT OF OSTEOARTHRITIS OF THE HIP EVIDENCE-BASED CLINICAL PRACTICE GUIDELINE Adopted by the American Academy of Orthopaedic Surgeons Board of Directors 3.13.17 Endorsed by: 1 Disclaimer This Clinical Practice Guideline was developed by an AAOS physician volunteer Guideline development group based on a systematic review of the current scientific and clinical information and accepted approaches to treatment

2017 American Academy of Orthopaedic Surgeons

113. Hip pain and mobility deficits&mdash

Hip pain and mobility deficits&mdash Hip pain and mobility deficits—hip osteoarthritis: revision 2017. | National Guideline Clearinghouse success fail May JUN 09 2017 2018 2019 18 May 2018 - 12 Jul 2018 COLLECTED BY Organization: Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites for the sake of history and digital heritage. The group is 100% composed (...) that WARC to ArchiveTeam servers for eventual injection into the Internet Archive (or other archive sites). To use ArchiveBot, drop by #archivebot on EFNet. To interact with ArchiveBot, you issue commands by typing it into the channel. Note you will need channel operator permissions in order to issue archiving jobs. The dashboard shows the sites being downloaded currently. There is a dashboard running for the archivebot process at . ArchiveBot's source code can be found at . TIMESTAMPS Search Sign

2017 National Guideline Clearinghouse (partial archive)

114. Predictors of Clinically Suspected Intra-articular Hip Symptoms and Prevalence of Hip Pathomorphologies Presenting to Sports Medicine and Hip Preservation Orthopaedic Surgeons. (Abstract)

intra-articular and hip joint-related symptoms.A total of 998 hips (499 patients, 228 males, 271 females, mean age 38 years) presented to 2 orthopaedic surgeons with the diagnosis of hip pain. Patients were retrospectively identified as intra-articular and hip joint-related symptoms or extra-articular and non-hip joint-related symptoms based on history, examination, injection response, and diagnosis listed on clinical notes. A detailed morphologic evaluation of anteroposterior and 45° modified Dunn (...) Predictors of Clinically Suspected Intra-articular Hip Symptoms and Prevalence of Hip Pathomorphologies Presenting to Sports Medicine and Hip Preservation Orthopaedic Surgeons. The first purpose of the study was to evaluate the prevalence of various radiographic parameters and pathomorphologies for patients presenting with the diagnosis of hip pain. The second purpose of this study was to identify those pathomorphologies and radiographic parameters that were predictive of clinically suspected

2017 Arthroscopy

115. The Spread of Ultrasound-Guided Injectate From the Adductor Canal to the Genicular Branch of the Posterior Obturator Nerve and the Popliteal Plexus: A Cadaveric Study. (Abstract)

The Spread of Ultrasound-Guided Injectate From the Adductor Canal to the Genicular Branch of the Posterior Obturator Nerve and the Popliteal Plexus: A Cadaveric Study. The popliteal nerve plexus contributes to afferent knee-pain conduction. It is mainly formed by genicular branches from the posterior obturator and the tibial nerves, innervating the intra-articular and posterior knee region. A subinguinal obturator nerve block alleviates pain after total knee arthroplasty. Reduced hip adductor (...) motor function could be avoided by a posterior obturator nerve block inside the popliteal fossa.The aim of this study was to evaluate the spread of dye after a distal adductor canal (AC) injection to the popliteal fossa and coloring of the popliteal plexus and the genicular branch of the posterior obturator nerve by dissection. We also assessed the spread of dye into the popliteal fossa after a distal femoral triangle injection.Ten milliliters of dye was injected into the distal part of the AC in 10

2017 Regional Anesthesia and Pain Medicine

116. A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer

A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum (...) number of saved studies (100). Please remove one or more studies before adding more. A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details

2017 Clinical Trials

117. Patient compliance with new oral anticoagulants after major orthopaedic surgery: rivaroxaban and dabigatran compared with subcutaneous injection of fondaparinux Full Text available with Trip Pro

antithrombotic drug therapy with dabigatran (group D; GD, n=32 patients), rivaroxaban (group R; GR, n=38 patients) or fondaparinux (group F; GF, n=30 patients), to prevent deep vein thrombosis, was started immediately after surgery in 100 patients submitted to total hip arthroplasty.the patients had a mean age of 68.7±11 years and 62% were female. In GD, 87.5% of patients indicated that they preferred oral intake of medications to subcutaneous injection (12.5%). In GR, 84.2% declared a preference for oral (...) Patient compliance with new oral anticoagulants after major orthopaedic surgery: rivaroxaban and dabigatran compared with subcutaneous injection of fondaparinux the main purpose of our study was to compare patient compliance with the orally administered new oral anticoagulants (NOCs) dabigatran and rivaroxaban compared with subcutaneously injected fondaparinux after major orthopaedic surgery, and to assess patient preference for the oral vs subcutaneous administration route.prophylactic

2017 Joints Controlled trial quality: uncertain

118. Autologous Tenocyte Injection for the Treatment of Chronic Recalcitrant Gluteal Tendinopathy: A Prospective Pilot Study Full Text available with Trip Pro

Autologous Tenocyte Injection for the Treatment of Chronic Recalcitrant Gluteal Tendinopathy: A Prospective Pilot Study Gluteal tendinopathy is a common cause of lateral hip pain, and existing conservative treatment modalities demonstrate high symptom recurrence rates. Autologous tenocyte injection (ATI) is a promising cell therapy that may be useful for the treatment of gluteal tendinopathy.To investigate the safety and effectiveness of ATI, specifically in patients with chronic recalcitrant (...) of the patella tendon and propagated in a certified Good Manufacturing Practice (GMP) laboratory. In a secondary procedure, a single injection of 2 mL autologous tenocytes (2-5 × 106 cells/mL) suspended in patient serum was injected into the site of the pathological gluteal tendons under ultrasound guidance. Patients were assessed pre- and postinjection (3, 6, 12, and 24 months) using the Oxford Hip Score (OHS), a visual analog pain scale (VAS), the Short Form-36 (SF-36), and a satisfaction scale. Magnetic

2017 Orthopaedic journal of sports medicine

119. DanHong injection targets endothelin receptor type B and angiotensin II receptor type 1 in protection against cardiac hypertrophy Full Text available with Trip Pro

DanHong injection targets endothelin receptor type B and angiotensin II receptor type 1 in protection against cardiac hypertrophy Cardiac hypertrophy (CH) is an independent risk factor for cardiovascular diseases (CVDs). Mitigating or preventing CH is the most effective strategy for the treatment of CVDs. DanHong injection (DH) is a Chinese herbal medicine preparation (CHMP) widely used in clinical treatment of several CVDs in China. However, the direct targets and cellular mechanisms (...) for these protective effects remain unclear. This study was designed to illustrate the direct targets of DH in protecting against CH and investigate CH molecular pathogenesis. A hypertrophic cell model was induced by endothelin-1 (ET-1) on human induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs). Real time cellular analysis (RTCA) cardio system and high content analysis (HCA) were used to detect the changes in contractile function, morphology and protein level of hypertrophic hiPS-CMs. Agonist

2017 Oncotarget

120. A Case of Trigger-Point Injection-Induced Hypokalemic Paralysis Full Text available with Trip Pro

A Case of Trigger-Point Injection-Induced Hypokalemic Paralysis BACKGROUND Trigger-point injection (TPI) therapy is an effective modality for symptomatic treatment of myofascial pain. Serious adverse effects are rarely observed. In this report, we present the case of a 39-year-old man who experienced severe, transient hypokalemic paralysis in the context of TPI therapy with methylprednisolone, bupivacaine, and epinephrine. He was successfully treated with electrolyte replacement in a closely (...) monitored setting. CASE REPORT A 39-year-old man with no past medical history except for chronic left hip pain from a work-related injury received a TPI with methylprednisolone and bupivacaine. The TPI targeted the left iliopsoas tendon and was administered using ultrasound guidance. There were no immediately perceived complications, but within 12 h he presented with severe hypokalemic paralysis with a serum potassium 1.7 mmol/L. Judicious potassium repletion was initiated. Repeated tests after 6 h

2017 The American journal of case reports

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>